OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
December 17, 2014
Biomanufacturing capacity expansion uses modular cleanroom design and single-use technologies.
December 02, 2014
Outsourcing is taking on a greater role in the biopharmaceutical manufacturing industry.
November 15, 2014
Advanced analytical methods are speeding up the targeted evaluation of potential viral contaminants.
The authors present a validation study of an analytical method for the simultaneous determination of nine human cytokines in human K2-EDTA plasma.
The authors describe a rapid, single-point calibration approach for ICP–MS analysis of raw materials used in drug product manufacturing.
November 01, 2014
European CDMOs want into the US market, but entry options are limited.
October 02, 2014
The trend of exits from the CMO industry looks to be gaining momentum.
September 29, 2014
Multidirectional collaboration is critical for the new pharma business model; cloud-based information services can offer a communications alternative.
September 03, 2014
John S. Ross, executive vice president at Metrics Contract Services, provided commentary on the evolving role of contract services in solid/semi-solid dosage development and manufacturing.
Experts at Catalent Pharma Solutions provided commentary on the evolving role of contract services in analytical services, biologics drug development and manufacturing, and solid/semi-solid dosage development and manufacturing.